UBI Pharma Inc.

TPEX:6562 Stock Report

Market Cap: NT$1.7b

UBI Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chei-Hsiang Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownershipn/a
Management average tenure6.2yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Chei-Hsiang Chen

4.3yrs

Tenure

Dr. Chei-Hsiang Chen, Ph.D. has been President of UBI Pharma Inc. since January 2020 and has been its Chairperson since December 2019. He serves as General Manager at UBI Pharma Inc. Dr. Chen serves as the...

Leadership Team

NamePositionTenureCompensationOwnership
Chei-Hsiang Chen
Chairperson4.3yrsno datano data
Meng Han Xu
Manager of the Finance Department8.1yrsno datano data
Roger Kuo
Chief Operating Officer10.3yrsno datano data
Jia Hong
Manager of Accounting Departmentno datano datano data
Vivien Fan
Executive VP4.3yrsno datano data
Yan Ning Guo
COO of Pharmaceutical Business Center & Directorno datano datano data

6.2yrs

Average Tenure

Experienced Management: 6562's management team is seasoned and experienced (6.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Chei-Hsiang Chen
Chairperson4.4yrsno datano data
Vivien Fan
Executive VP4.3yrsno datano data
Yan Ning Guo
COO of Pharmaceutical Business Center & Directorno datano datano data
Yau-Huei Wei
Independent Director4.3yrsno datano data
Shijia Lin
Directorno datano datano data

4.3yrs

Average Tenure

Experienced Board: 6562's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/12 16:47
End of Day Share Price 2024/05/10 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UBI Pharma Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution